Literature DB >> 15578708

Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.

Thomas E Yankeelov1, William D Rooney, Wei Huang, Jonathan P Dyke, Xin Li, Alina Tudorica, Jing-Huei Lee, Jason A Koutcher, Charles S Springer.   

Abstract

The standard pharmacokinetic model for the analysis of MRI contrast reagent (CR) bolus-tracking (B-T) data assumes that the mean intracellular water molecule lifetime (tau(i)) is effectively zero. This assertion is inconsistent with a considerable body of physiological measurements. Furthermore, theory and simulation show the B-T time-course shape to be very sensitive to the tau(i) magnitude in the physiological range (hundreds of milliseconds to several seconds). Consequently, this standard model aspect can cause significant underestimations (factors of 2 or 3) of the two parameters usually determined: K(trans), the vascular wall CR transfer rate constant, and v(e), the CR distribution volume (the extracellular, extravascular space fraction). Analyses of animal model data confirmed two predicted behaviors indicative of this standard model inadequacy: (1) a specific temporal pattern for the mismatch between the best-fitted curve and data; and (2) an inverse dependence of the curve's K(trans) and v(e) magnitudes on the CR dose. These parameters should be CR dose-independent. The most parsimonious analysis allowing for realistic tau(i) values is the 'shutter-speed' model. Its application to the experimental animal data essentially eliminated the two standard model signature inadequacies. This paper reports the first survey for the extent of this 'shutter-speed effect' in human data. Retrospective analyses are made of clinical data chosen from a range of pathology (the active multiple sclerosis lesion, the invasive ductal carcinoma breast tumor, and osteosarcoma in the leg) that provides a wide variation, particularly of K(trans). The signature temporal mismatch of the standard model is observed in all cases, and is essentially eliminated by use of the shutter-speed model. Pixel-by-pixel maps show that parameter values from the shutter-speed analysis are increased by more than a factor of 3 for some lesion regions. This endows the lesions with very high contrast, and reveals heterogeneities that are often not seen in the standard model maps. Normal muscle regions in the leg allow validation of the shutter-speed model K(trans), v(e), and tau(i) magnitudes, by comparison with results of previous careful rat leg studies not possible for human subjects. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15578708     DOI: 10.1002/nbm.938

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  52 in total

1.  The concordance of MRI and quantitative autoradiography estimates of the transvascular transfer rate constant of albumin in a rat brain tumor model.

Authors:  Ramesh Paudyal; James R Ewing; Tavarekere N Nagaraja; Hassan Bagher-Ebadian; Robert A Knight; Swayamprava Panda; Mei Lu; Karyn Ledbetter; Joseph D Fenstermacher
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

2.  Modeling of Look-Locker estimates of the magnetic resonance imaging estimate of longitudinal relaxation rate in tissue after contrast administration.

Authors:  Ramesh Paudyal; Hassan Bagher-Ebadian; Tavarekere N Nagaraja; Joseph D Fenstermacher; James R Ewing
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

3.  Observation of Reduced Homeostatic Metabolic Activity and/or Coupling in White Matter Aging.

Authors:  Valerie C Anderson; Ian J Tagge; Xin Li; Joseph F Quinn; Jeffrey A Kaye; Dennis N Bourdette; Rebecca I Spain; Louis P Riccelli; Manoj K Sammi; Charles S Springer; William D Rooney
Journal:  J Neuroimaging       Date:  2020-06-17       Impact factor: 2.486

4.  Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

Authors:  Thomas E Yankeelov; Martin Lepage; Anuradha Chakravarthy; Elizabeth E Broome; Kenneth J Niermann; Mark C Kelley; Ingrid Meszoely; Ingrid A Mayer; Cheryl R Herman; Kevin McManus; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2006-11-21       Impact factor: 2.546

5.  Incorporating the effects of transcytolemmal water exchange in a reference region model for DCE-MRI analysis: theory, simulations, and experimental results.

Authors:  Thomas E Yankeelov; Jeffrey J Luci; Laura M DeBusk; P Charles Lin; John C Gore
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

6.  Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Authors:  S Kim; L A Loevner; H Quon; A Kilger; E Sherman; G Weinstein; A Chalian; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-01       Impact factor: 3.825

7.  Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison study.

Authors:  Chunhao Wang; Ergys Subashi; Xiao Liang; Fang-Fang Yin; Zheng Chang
Journal:  Phys Med Biol       Date:  2016-06-08       Impact factor: 3.609

8.  Modification of population based arterial input function to incorporate individual variation.

Authors:  Harrison Kim
Journal:  Magn Reson Imaging       Date:  2017-09-27       Impact factor: 2.546

9.  The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Eugene Y Chang; Xin Li; Michael Jerosch-Herold; Ryan A Priest; C Kristian Enestvedt; Jingang Xu; Charles S Springer; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

10.  Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

Authors:  R Jain; S K Ellika; L Scarpace; L R Schultz; J P Rock; J Gutierrez; S C Patel; J Ewing; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.